Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
VC Roundup: 8-figure funding deals suggest crypto bull market far from over
Enterprise Web3 company Crossmint has closed a $23.6 million funding round to scale its onchain onboarding technology, which ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
A look at Intel Capital before the 34-year-old firm strikes out on its own
Intel Capital is set to spin out from its parent company later this year after serving as Intel's venture investing arm since 1991.